317 related articles for article (PubMed ID: 17692905)
1. Endothelial capillary tube formation and cell proliferation induced by tumor cells are affected by low molecular weight heparins and unfractionated heparin.
Marchetti M; Vignoli A; Russo L; Balducci D; Pagnoncelli M; Barbui T; Falanga A
Thromb Res; 2008; 121(5):637-45. PubMed ID: 17692905
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of the low-molecular-weight heparin, dalteparin, and unfractionated heparin on microvascular endothelial cell hemostatic properties.
Vignoli A; Marchetti M; Balducci D; Barbui T; Falanga A
Haematologica; 2006 Feb; 91(2):207-14. PubMed ID: 16461305
[TBL] [Abstract][Full Text] [Related]
3. Low-molecular-weight heparins and angiogenesis.
Norrby K
APMIS; 2006 Feb; 114(2):79-102. PubMed ID: 16519745
[TBL] [Abstract][Full Text] [Related]
4. LMWH bemiparin and ULMWH RO-14 reduce the endothelial angiogenic features elicited by leukemia, lung cancer, or breast cancer cells.
Vignoli A; Marchetti M; Russo L; Cantalino E; Diani E; Bonacina G; Falanga A
Cancer Invest; 2011 Feb; 29(2):153-61. PubMed ID: 21261475
[TBL] [Abstract][Full Text] [Related]
5. Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro.
Collen A; Smorenburg SM; Peters E; Lupu F; Koolwijk P; Van Noorden C; van Hinsbergh VW
Cancer Res; 2000 Nov; 60(21):6196-200. PubMed ID: 11085545
[TBL] [Abstract][Full Text] [Related]
6. Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight.
Khorana AA; Sahni A; Altland OD; Francis CW
Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2110-5. PubMed ID: 12920044
[TBL] [Abstract][Full Text] [Related]
7. Low molecular weight heparin suppresses lymphatic endothelial cell proliferation induced by vascular endothelial growth factor C in vitro.
Cao G; Wu JX; Wu QH
Chin Med J (Engl); 2009 Jul; 122(13):1570-4. PubMed ID: 19719950
[TBL] [Abstract][Full Text] [Related]
8. Effects of unfractionated and fractionated heparins on myeloperoxidase activity and interactions with endothelial cells: possible effects on the pathophysiology of equine laminitis.
de la Rebière G; Franck T; Deby-Dupont G; Salciccia A; Grulke S; Péters F; Serteyn D
Vet J; 2008 Oct; 178(1):62-9. PubMed ID: 17942351
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of unfractionated heparin and the low-molecular-weight heparins dalteparin and enoxaparin on spontaneous platelet aggregation and adenosine diphosphate activity in platelets during the third trimester of pregnancy.
Ajayi AA; Pharmacols FB; Cooper J; Horn EH; Rubin PC
Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):539-45. PubMed ID: 18040530
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate.
Chintalapati M; Truax R; Stout R; Portier R; Losso JN
J Agric Food Chem; 2009 Jun; 57(12):5201-10. PubMed ID: 19476359
[TBL] [Abstract][Full Text] [Related]
11. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
12. Effect of unfractionated heparin and a low molecular weight heparin (enoxaparin) on coagulant activity of cultured human endothelial cells.
Martinez-Sales V; Vila V; Réganon E; Oms JG; Aznar J
Haematologica; 2003 Jun; 88(6):694-9. PubMed ID: 12801846
[TBL] [Abstract][Full Text] [Related]
13. Undersulfated, low-molecular-weight glycol-split heparin as an antiangiogenic VEGF antagonist.
Pisano C; Aulicino C; Vesci L; Casu B; Naggi A; Torri G; Ribatti D; Belleri M; Rusnati M; Presta M
Glycobiology; 2005 Feb; 15(2):1C-6C. PubMed ID: 15496501
[TBL] [Abstract][Full Text] [Related]
14. (+)-Catechin inhibits tumour angiogenesis and regulates the production of nitric oxide and TNF-alpha in LPS-stimulated macrophages.
Guruvayoorappan C; Kuttan G
Innate Immun; 2008 Jun; 14(3):160-74. PubMed ID: 18562575
[TBL] [Abstract][Full Text] [Related]
15. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules.
Nizamutdinova IT; Lee GW; Lee JS; Cho MK; Son KH; Jeon SJ; Kang SS; Kim YS; Lee JH; Seo HG; Chang KC; Kim HJ
Carcinogenesis; 2008 Oct; 29(10):1885-92. PubMed ID: 18586687
[TBL] [Abstract][Full Text] [Related]
17. Low molecular weight fucoidan and heparin enhance the basic fibroblast growth factor-induced tube formation of endothelial cells through heparan sulfate-dependent alpha6 overexpression.
Chabut D; Fischer AM; Colliec-Jouault S; Laurendeau I; Matou S; Le Bonniec B; Helley D
Mol Pharmacol; 2003 Sep; 64(3):696-702. PubMed ID: 12920206
[TBL] [Abstract][Full Text] [Related]
18. Bemiparin and fluid flow modulate the expression, activity and release of tissue factor pathway inhibitor in human endothelial cells in vitro.
Westmuckett AD; Kakkar VV; Hamuro T; Lupu F; Lupu C
Thromb Haemost; 2001 Dec; 86(6):1547-54. PubMed ID: 11776326
[TBL] [Abstract][Full Text] [Related]
19. Anti-angiogenic activity of heparin-like polysulfonated polymeric drugs in 3D human cell culture.
García-Fernández L; Halstenberg S; Unger RE; Aguilar MR; Kirkpatrick CJ; San Román J
Biomaterials; 2010 Nov; 31(31):7863-72. PubMed ID: 20674006
[TBL] [Abstract][Full Text] [Related]
20. The anti-angiogenic effects of 1-furan-2-yl-3-pyridin-2-yl-propenone are mediated through the suppression of both VEGF production and VEGF-induced signaling.
Park BC; Park SY; Lee JS; Mousa SA; Kim JT; Kwak MK; Kang KW; Lee ES; Choi HG; Yong CS; Kim JA
Vascul Pharmacol; 2009; 50(3-4):123-31. PubMed ID: 19068239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]